Anti-amyloid monoclonal antibody therapies in Alzheimer’s disease – a scoping review
<p dir="ltr">Alzheimer’s disease (AD) is a progressive neurodegenerative disorder affecting millions worldwide, and with advancements in the medical field, Anti-amyloid monoclonal antibodies (AA mAbs) targeting amyloid-β have emerged as potential disease-modifying agents altering AD...
محفوظ في:
| المؤلف الرئيسي: | Shahd Abubaker Elamin (22569539) (author) |
|---|---|
| مؤلفون آخرون: | Aous N. Al Shibli (22569540) (author), Abdullah Shaito (20545181) (author), Mazyona J.M.B. Al-Maadhadi (22569543) (author), Monica Zolezzi (10115698) (author), Shona Pedersen (2792278) (author) |
| منشور في: |
2025
|
| الموضوعات: | |
| الوسوم: |
إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
|
مواد مشابهة
-
Novel Federated Decision Making for Distribution of Anti-SARS-CoV-2 Monoclonal Antibody to Eligible High-Risk Patients
حسب: AlSereidi, Abeer
منشور في: (2022) -
Federal Multi Criteria Decision Making Framework in Distribution of Anti-SARS-CoV-2 Monoclonal Antibody to Eligible High-Risk Patients as Case Study
حسب: ALSEREIDI, ABEER
منشور في: (2022) -
Screening for Novel Inhibitors of Amyloid Beta Aggregation and Toxicity as Potential Drugs for Alzheimer’s Disease
حسب: Sanaa Sharari (12561952)
منشور في: (2023) -
Glucose excursions in type 2 diabetes modulate amyloid-related proteins associated with dementia
حسب: Abu Saleh Md Moin (6189512)
منشور في: (2021) -
Mitochondrial dysfunction: A notable contributor to the progression of Alzheimer's and Parkinson's disease
حسب: Abolaji Samson Olagunju (16855185)
منشور في: (2023)